BCST Board Members

Co-Chairs

Timothy Swager, NAS, Massachusetts Institute of Technology

David Walt, NAE, Tufts University

 

Members

Héctor D. Abruña, Cornell University

Joel C. Barrish, Bristol-Myers Squibb

Mark Barteau, NAE, University of Michigan

David Bem, The Dow Chemical Company

Robert G. Bergman, NAS, University of California, Berkeley

Joan Brennecke, NAE, Notre Dame University

Henry E. Bryndza, E. I. du Pont de Nemours & Company

Michelle V. Buchanan, Oak Ridge National Laboratory

David W. Christianson, University of Pennsylvania

Richard Eisenberg, NAS, University of Rochester

Jill Hruby, Sandia National Laboratories

Frances S. Ligler, NAE, University of North Carolina, Chapel Hill, and North Carolina State University

Sander G. Mills, Merck, Sharp, & Dohme Corporation

Joseph B. Powell, Shell

Robert E. Roberts, Institute for Defense Analyses

Peter J. Rossky, NAS, Rice University

Darlene J. S. Solomon, Agilent Technologies


Board Members Biographies 


Board on Chemical Sciences and Technology

 

Biographies

 

Timothy Swager (co-chair), NAS, is the John D. MacArthur Professor of Chemistry at the Massachusetts Institute of Technology. A native of Montana, he received a BS from Montana State University in 1983 and a Ph.D. from the California Institute of Technology in 1988.  After a postdoctoral appointment at MIT he was on the chemistry faculty at the University of Pennsylvania and returned to MIT in of 1996 as a Professor of Chemistry and served as the Head of Chemistry from 2005-2010.  He has published more than 350 peer-reviewed papers and more than 50 issued/pending patents. Swager's honors include: Election to the National Academy of Sciences, an Honorary Doctorate from Montana State University, the Lemelson-MIT Award for Invention and Innovation, Election to the American Academy of Arts and Sciences, The American Chemical Society Award for Creative Invention, The Christopher Columbus Foundation Homeland Security Award, and The Carl S. Marvel Creative Polymer Chemistry Award (ACS). Swager's research interests are in design, synthesis, and study of organic-based electronic, sensory, high-strength and liquid crystalline materials.  His liquid crystal designs demonstrated shape complementarity to generate specific interactions between molecules and includes fundamental mechanisms for increasing liquid crystal order by a new mechanism referred to as minimization of free volume. Swager's research in electronic polymers has been mainly directed at the demonstration of new conceptual approaches to the construction of sensory materials.  These methods are the basis of the FidoTM explosives detectors (FLIR Systems Inc), which have the highest sensitivity of any explosives sensor.   Other areas actively investigated by the Swager group include radicals for dynamic nuclear polarization, applications of nano-carbon materials, organic photovoltaic materials, polymer actuators, and luminescent molecular probes for medical diagnostics.  He is the founder of 4 companies (DyNuPol, Iptyx, PolyJoule, and C­2 Sense) and has served on a number of corporate and government boards.

 

David R. Walt (co-chair), NAE, is University Professor, Robinson Professor of Chemistry, Professor of Genetics, Professor of Biomedical Engineering at Tufts University and is a Howard Hughes Medical Institute Professor.  He also is the Director of the Tufts Institute for Innovation. He received a B.S. in chemistry from the University of Michigan and a Ph.D. in chemical biology from SUNY at Stony Brook. His laboratory pioneered the development of microwell arrays, which resulted in the discovery of bead arrays that revolutionized the field of genetic analysis.  Dr. Walt's laboratory also introduced the idea of digital protein detection by developing a high throughput technology for performing single molecule analysis.  Present efforts in the laboratory are aimed at measuring the variation of protein and gene expression in single cells, fundamental studies of populations of single enzyme molecules and single nanoparticles, as well as the ultrasensitive detection of biomarkers for cancer and infectious disease.  Dr. Walt is the Scientific Founder and a Director of both Illumina Inc. and Quanterix Corp. Dr. Walt has published over 300 peer-reviewed papers and has over 75 issued US patents.  He has received numerous national and international awards and honors for his fundamental and applied work in the field of optical arrays and single molecules including the American Chemical Society Gustavus John Esselen Award (2014), Analytical Chemistry Spectrochemical Analysis Award (2013), the Pittsburgh Analytical Chemistry Award (2013), and the ACS National Award for Creative Invention (2010). He is a member of the National Academy of Engineering, a Fellow of the American Academy of Arts and Sciences a Fellow of the American Institute for Medical and Biological Engineering, and a Fellow of the National Academy of Inventors. He has served on a number of NRC committees and served as chair for the Committee on Transforming Glycoscience.

 

Héctor D. Abruña, émile M. Chamot Professor of Chemistry, completed his graduate studies with Royce W. Murray and Thomas J. Meyer at the University of North Carolina at Chapel Hill in 1980 and was a Postdoctoral Research Associate with Allen J. Bard at the University of Texas at Austin. After a brief stay at the University of Puerto Rico, he moved to Cornell in 1983. Professor Abruña is an AAAS Fellow and a member of the American Academy of Arts and Sciences. He is a recipient of a Presidential Young Investigator Award, an Alfred P. Sloan Foundation Research Fellowship, a John S. Guggenheim Fellowship, the Tajima Prize of the International Society of Electrochemistry, and a J. W. Fulbright Senior Research Fellowship. Dr. Abruña's research focuses on the development and characterization of new materials using a wide variety of techniques for fuel cells, batteries, and molecular assemblies for molecular electronics. 

 

Joel C. Barrish is currently Vice President of Discovery Chemistry at Bristol-Myers Squibb.  He graduated from the University of Pennsylvania in 1979, and received a doctorate in Organic Chemistry in January 1983 from Columbia University working with Professor W. Clark Still.  Over the next 5 years, first as a postdoctoral associate and then as a Senior Scientist, Joel worked in the Natural Products Department at Hoffmann-LaRoche in Nutley, New Jersey under the direction of Dr. Milan Uskokovic.  In 1988, he moved to Bristol-Myers Squibb where over the last 26 years he has assumed positions of greater responsibility while working in several therapeutic areas including Cardiovascular agents, Antivirals, Oncology, Immunosciences, and Metabolic Diseases.  He was responsible for teams that advanced more than 20 compounds into clinical development, including SPRYCELâ (dasatinib) of which he is also a co-inventor.  Dasatinib is a BCR-ABL inhibitor that has significantly contributed to the treatment of chronic myeloid leukemia patients since its approval in 2006; he and his co-inventors received the 2008 Thomas Alva Edison Patent Award for its discovery. Since 1995, Joel and his BMS colleagues in Immunosciences and Oncology have made notable advancements in the area of kinase inhibitor drug discovery which have been published extensively in the primary literature.  Joel is a co-author on over 115 peer reviewed publications, a co-inventor on more than 35 issued U.S. patents, and has been invited to give more than 30 lectures at international conferences and universities.  In 2010, Joel was elected to the Executive Committee of the MEDI Division of the American Chemical Society and served as Chair in 2013.  He was also named an ACS Fellow in July 2012.  

 

Mark A. Barteau, NAE, is the DTE Energy Professor of Advanced Energy Research and Director of the University of Michigan Energy Institute at the University of Michigan in Ann Arbor. Before joining the University of Michigan in 2012, he served as the Senior Vice Provost for Research and Strategic Initiatives at the University of Delaware, where he held appointments as the Robert L. Pigford Endowed Chair of Chemical Engineering and Professor of Chemistry & Biochemistry.  He received his BS degree in Chemical Engineering from Washington University in St. Louis, and his MS and PhD from Stanford, working with Professor Robert J. Madix.  He joined the University of Delaware faculty as an assistant professor of chemical engineering and associate director of the Center for Catalytic Science and Technology in 1982.  Dr. Barteau's research, presented in more than 240 publications and a similar number of invited lectures, focuses on chemical reactions at solid surfaces, and their applications in heterogeneous catalysis for energy and chemical processes. Dr. Barteau was named in 2008 as one of the "100 Engineers of the Modern Era" by the American Institute of Chemical Engineers. He is the recipient of numerous awards, including the 2001 Alpha Chi Sigma Award and the 1991 Allan P. Colburn Award, presented by AIChE; the 1998 International Catalysis Award, presented by the International Association of Catalysis Societies; the 1995 Ipatieff Prize from the American Chemical Society; the Paul H. Emmett Award in Fundamental Catalysis, given by the North American Catalysis Society, and the 1993 Canadian Catalysis Lecture Tour Award of the Catalysis Division of the Chemical Institute of Canada.  He has served as associate editor of the AIChE Journal and WIRES Energy and Environment, and on the editorial boards of a number of other journals, including Industrial & Engineering Chemistry Research and the Journal of Catalysis. Dr. Barteau was elected to the National Academy of Engineering in 2006.

 

David Bem received a B.A. in chemistry from West Virginia University in 1990 and a Ph.D. in inorganic chemistry from Massachusetts Institute of Technology in 1995.  Dr. Bem began his career at UOP, a Honeywell Company, focused on the synthesis and applications of zeolites and microporous materials. While at UOP, he led the discovery and development of PI-242, a high activity catalyst for butane isomerization. In 2000, he became R&D Director of Torial, a subsidiary of UOP, and developed and commercialized high throughput tools for heterogeneous catalysis. In 2002, Dr. Bem joined Celanese Corporation as R&D Director for acetyls, oxygenates, and acetone derivatives where he was responsible for advancements in AO+™ (acetic acid technology) and Vantage Plus™ (vinyl acetate technology). In 2005, he became a member of the Celanese Corporate Executive Committee and R&D Director for Engineering Polymers/Ticona.  Dr. Bem joined Dow in 2007 and has held leadership positions in R&D Hydrocarbons & Energy, Alternative Feedstocks, and Basic Chemicals; in 2008 he became director of Dow Automotive.  He assumed his current role in November 2010 as leader of the Core R&D organization and the Corporate Innovation Fund, which allows for early stage exploration of disruptive technologies and the development of new businesses. Dr. Bem was recently appointed to the Scientific Advisory Board for Oakridge National Laboratories Energy and Environmental Sciences Directorates.  He is a frequent lecturer and panelist on Energy and Sustainability at technical conferences.  In 2012, Dr. Bem was a University of Pennsylvania Technology, Business, and Governmental Lecturer and also spoke on this topic at the Council for Chemical Research's annual meeting in May and the 4th International Congress on Ceramics (ICC4) in June. Dr. Bem is a passionate endorser of STEM education and has been invited to participate in numerous mentoring activities, serve on panels, and speak at universities and conferences about careers in chemistry. Dr. Bem recently spoke at the 18th Annual C. Eugene and Edna P. Bennett Careers for Chemists Program, was a panelist at the ACS Tech-knowledge-y Event at Delta College, and also has plans to visit Wayne State University this fall to present a technical lecture as well as to serve as panelist for a careers in chemistry session. Dr. Bem holds nine US patents and has authored more than 20 publications.

 

Robert Bergman, NAS, received his Ph.D. at the University of Wisconsin in 1966 under the direction of Jerome A. Berson.  He spent 1966-67 as a postdoctoral fellow in Ronald Breslow's laboratories at Columbia, and following that joined the faculty of the California Institute of Technology.  After ten years at Caltech, he accepted a professorship at the University of California, Berkeley, and a joint appointment at the Lawrence Berkeley National Laboratory; in 2002, he was appointed Gerald E.K. Branch Distinguished Professor at Berkeley.  Among his honors are a Sloan Foundation Fellowship, a Dreyfus Foundation Teacher-Scholar Award, the American Chemical Society Award in Organometallic Chemistry, election to membership in the U.S. National Academy of Sciences and American Academy of Arts and Sciences, the U.S. Department of Energy E.O., Lawrence Award in Chemistry, the American Chemical Society Arthur C. Cope Award, the Royal Society of Chemistry Sir Edward Frankland Prize Lectureship, Willard Gibbs Award (ACS Chicago Section), ACS Fellow, Distinguished Graduate Student Mentoring Award, Honorary Doctorate from Texas A&M University, ACS George Olah Award in Hydrocarbon Chemistry, Welch Foundation Award in Chemistry, and Robert Robinson Award-Royal Society of Chemistry's (RSC) Organic Division.  Dr. Bergman has long been interested in exploratory and mechanistic studies in organic and organotransition metal chemistry.  He is probably best known for his discovery of the thermal cyclization of cis-1,5-hexadiyne-3-enes to l,4-dehydrobenzene diradicals, a transformation that has been identified as a crucial DNA-cleaving reaction in several antibiotics that bind to nucleic acids, his discovery of the first soluble organometallic complexes that undergo intermolecular insertion of transition metals into the carbon-hydrogen bonds of alkanes, and his work on the synthesis and cycloaddition reactions of complexes with metal-heteroatom multiple bonds.  His research has recently expanded to include application of carbon-hydrogen bond activation to problems in synthetic organic chemistry, nanovessel catalysis, and methods for the conversion of biomass to fuels and commodity chemicals.  Dr. Bergman holds eight U.S. patents and has authored more than 575 publications.

 

Joan F. Brennecke, NAE, is the Keating-Crawford Professor of Chemical Engineering at the University of Notre Dame and was the founding Director of the Center for Sustainable Energy at Notre Dame.   She joined Notre Dame after completing her Ph.D. and M.S. (1989 and 1987) degrees at the University of Illinois at Urbana-Champaign and her B. S. at the University of Texas at Austin (1984).

 

Her research interests are primarily in the development of less environmentally harmful solvents.  These include supercritical fluids and ionic liquids. In developing these solvents, Dr. Brennecke's primary interests are in the measurement and modeling of thermodynamics, thermophysical properties, phase behavior and separations.  Major awards include 2001 Ipatieff Prize from the American Chemical Society, the 2006 Professional Progress Award from the American Institute of Chemical Engineers, the J. M. Prausnitz Award at the Eleventh International Conference on Properties and Phase Equilibria in Greece in May, 2007, the 2008 Stieglitz Award from the American Chemical Society, the 2009 E. O. Lawrence Award from the U.S. Department of Energy, and the 2014 E. V. Murphree Award in Industrial and Engineering Chemistry from the American Chemical Society.  She serves as Editor-in-Chief of the Journal of Chemical & Engineering Data.  Her 130+ research publications have garnered over 11,000 citations.  She was inducted into the National Academy of Engineering in 2012.

 

Henry E. Bryndza is currently the Director for Biotechnology (formerly Bio Chemical Sciences & Engineering). His role includes all aspects of strategic technology planning and execution of research, development and commercialization of new and improved products and processes and new business initiatives in the chemical sciences and engineering and biomaterials arenas.

 

Dr. Bryndza has broad expertise in the field of chemical technologies for new and improved product and process development in the manufacture of green chemicals, polymers, specialties and inorganic materials. He has an international reputation in homogeneous catalysis, physical organometallic/organic chemistry, green chemistry & sustainability and chemical technologies as well as in the rehabilitation of oiled wildlife.

 

Prior to his current positions, Dr. Bryndza served as Technology Director for DuPont Applied Bio Sciences where he was responsible for initiatives in bio fuels, bio materials and bio specialties with a focus on applications development and new product commercialization. He was also the Technology Director for the DuPont Chemical Solutions Enterprise where he served as a liaison with internal and external customers around the world as well as with stakeholders including government agencies and non-governmental organizations. As a research manager he was responsible for development and execution of long-range technology strategies for a broad suite of chemical and materials businesses within DuPont including DuPont Titanium Technologies, DuPont Engineering Polymers, DuPont Packaging and Industrial Polymers, DuPont Performance Coatings, DuPont Fluoroproducts and DuPont Chemical Solutions Enterprise.

 

Dr. Bryndza has been with DuPont since 1981. He has published 32 papers, has been issued 8 patents, presented at over 55 international meetings and lectured over 100 times at top universities. He serves on the board of the U.S. National Academy of Sciences Board on Chemical Sciences & Technologies and the American Chemical Society Executive Director’s Vision 2020 Committee.

 

Dr. Bryndza received his BS from Massachusetts Institute of Technology and his Ph.D. from the University of California at Berkeley.

 

Michelle V. Buchanan, Associate Laboratory Director for Physical Sciences, oversees four Oak Ridge National Laboratory (ORNL) research divisions: the Center for Nanophase Materials Science, Chemical Sciences, Materials Science and Technology, and Physics. She is responsible for two offices in the Department of Energy Office of Science Program: Basic Energy Sciences and Nuclear Physics.  Prior to assuming her current position, she served as Director of the ORNL Chemical Sciences Division from October 2000 to November 2004. She served as Associate Director of the Life Sciences Division from January 1999 to September 2000. She initiated the Center for Structural Molecular Biology at ORNL, serving as its director from 1999 to 2003, and led the Organic and Biological Mass Spectrometry Group in the Chemical and Analytical Sciences Division (now the Chemical Sciences Division) from 1986 to 1999. She joined ORNL in 1978 after earning a B.S. in chemistry from the University of Kansas in Lawrence, Kansas, and a Ph.D. in analytical chemistry from the University of Wisconsin in Madison.

 

Dr. Buchanan is the author or co-author of more than 150 scientific publications and reports, holds two patents, and was editor of a book on Fourier transform mass spectrometry.  She was North American editor of Biological Mass Spectrometry and has served on the editorial boards of Analytical Chemistry, Organic Mass Spectrometry, Journal of Mass Spectrometry, Biological and Environmental Mass Spectrometry, and Fresenius' Journal of Analytical Chemistry. She received an R&D 100 Award in 1986; ORNL Technical Achievement Awards in 1985, 1989, and 1993; UT-Battelle awards for R&D Leadership in 2000 and 2002; and the Knoxville YWCA Tribute to Women award in science and technology in 2003.

 

Dr. Buchanan is a Fellow of the American Chemical Society (ACS) and currently serves as a Councilor for the Division of Analytical Chemistry (DAC) and as a member of the Divisional Activities Committee of the ACS.  She has served as a member of the International Activities Committee for ACS, treasurer for DAC ACS, treasurer for the American Society for Mass Spectrometry, and chair of the East Tennessee Section of the ACS. She also served on numerous advisory boards of universities and for major research centers. Current board memberships include the University of North Carolina-Chapel Hill, Cornell University, the University of Wisconsin-Madison, and the University of Tennessee. Over the past decade she has worked at the national level helping define basic research needs in a number of key energy-related areas.

 

David W. Christianson is the Roy and Diana Vagelos Professor in Chemistry and Chemical Biology at the University of Pennsylvania. His research focuses on the structural and chemical biology of metal-dependent enzymes such as the arginases and their evolutionary relatives (e.g., the histone deacetylases), and the terpenoid synthases, which catalyze the most complex carbon-carbon bond forming reactions in biology. Dr. Christianson received his A.B. degree in chemistry from Harvard College in 1983 and his Ph.D. from Harvard University in 1987, after which he joined the Penn faculty in 1988. He has received numerous awards, including the Searle Scholar Award (1989-1992), the Young Investigator Award from the Office of Naval Research (1989-1992), the Camille and Henry Dreyfus Teacher-Scholar Award (1993-1994), the Pfizer Award in Enzyme Chemistry from the American Chemical Society (1999), a Guggenheim Fellowship (2006), the Underwood Fellowship from the Biotechnology and Biological Sciences Research Council of the United Kingdom to support a Visiting Professorship in the Department of Biochemistry at the University of Cambridge (2006-2007), and the Repligen Award in the Chemistry of Biological Processes from the American Chemical Society (2013). In 2008, Dr. Christianson founded the biopharmaceutical company Arginetix to commercialize arginase inhibitors developed in his Penn laboratory for applications in cardiovascular medicine.

 

Richard Eisenberg, NAS, is Tracy Harris Professor Emeritus and Professor (Research) at the University of Rochester.  He received his undergraduate and graduate degrees from Columbia University, joined the faculty at Brown University in 1967 and moved to the University of Rochester in 1973. He served as Chair of the UR Chemistry Department from 1991-'94 and was named to the Harris Chair in 1996.  Eisenberg's research interests are in inorganic and organometallic chemistry, photochemistry relating to solar energy conversion, and catalysis.  Foremost among his activities in the chemistry community, Eisenberg was the Editor-in-Chief of Inorganic Chemistry for twelve years, stepping down at the end of 2012.  He has also served as Chair of the Inorganic Chemistry Division, and as a member of the editorial advisory boards of the Journal of the American Chemical Society, Inorganic Chemistry, Organometallics and Accounts of Chemical Research.  He has been the recipient of a number of awards including the 2003 ACS Award for Distinguished Service in the Advancement of Inorganic Chemistry and shared the 2011 ACS Nobel Laureate Signature Award in Graduate Education with his student Ping-wu Du.  In 2010, he received the Lifetime Achievement Award for Graduate Education from the University of Rochester.  Eisenberg was elected a Fellow of the American Association for the Advancement of Science in 2005, a Fellow of the American Academy of Arts and Sciences in 2009, and a Member of the U. S. National Academy of Sciences in 2010. In 2012, he received the Fred Basolo Medal from the Chicago Section of the ACS, and in 2013, he was the recipient of the William H. Nichols Medal of the New York Section of the ACS and the Ralph Oesper Award of the Cincinnati Section of the ACS. He is an Associate Editor for the Proceedings of the National Academy of Sciences.  Eisenberg has taught chemistry at all levels including an innovative freshman year majors course based on Energy and the Environment and has mentored more than eighty Ph.D. and postdoctoral research students.

 

Jill Hruby is the Sandia National Laboratories vice president for energy, non-proliferation, and high consequence security.  Her organization primarily conducts research and development in renewable energy and grid resilience, nuclear power, geoscience, preventing proliferation of weapons of mass destruction and the global threat of terrorism, and the protection of nuclear materials and vital national assets.  Ms. Hruby also leads Sandia's International, Homeland, and Nuclear Security Program Management Unit, including Sandia's strategic missions of reducing global nuclear and global biological dangers.  Ms. Hruby has expertise in understanding the threat as well as prevention and recovery from the world's most dangerous events. Prior to her current position, Ms. Hruby was the director of Homeland Security and Defense Systems and has been with Sandia for more than 30 years. She has served as Sandia's director of materials and engineering sciences, where she was responsible for materials research and development and microsystem fabrication and performance. Over the course of her Sandia career, she has also been actively engaged with nanoscience research, hydrogen storage, solar energy research, nuclear and radiological detection, biological and chemical defense, mechanical component design, thermal analysis, and microfluidics.  She holds a BS in mechanical engineering from Purdue University and MS in mechanical engineering from the University of California, Berkeley.  Ms. Hruby currently serves on the Threat Reduction Advisory Committee for the Department of Defense.

 

Frances S. Ligler, NAE, is the Lampe Distinguished Professor of Biomedical Engineering in the Joint Department of Biomedical Engineering in the College of Engineering at North Carolina State University and School of Medicine at the University of North Carolina at Chapel Hill and an elected member, past chair of the Bioengineering Section, and Councillor of the National Academy of Engineering. She earned a B.S. from Furman University and both a D.Phil. and a D.Sc. from Oxford University. Currently working in the fields of biosensors and microfluidics, she has also performed research in biochemistry, immunology, and proteomics. She has over 375 full-length publications and patents, which have led to eleven commercial biosensor products and have been cited over 9000 times. She is the winner of the Navy Superior Civilian Service Medal, the National Drug Control Policy Technology Transfer Award, the Chemical Society Hillebrand Award, the Navy Merit Award, the Naval Research Laboratory (NRL) Technology Transfer Award, three NRL Edison Awards for Patent of the Year, the Furman University Bell Tower and Distinguished Alumni of the 20th Century Awards, and the national Women in Science and Engineering (WISE) Outstanding Achievement in Science Award. She serves as an Associate Editor of Analytical Chemistry and on editorial/advisory boards for Biosensors & Bioelectronics, Analytical Bioanalytical Chemistry, Sensors, Open Optics, and Applied Biochemistry and Biotechnology. Elected an SPIE Fellow in 2000, a Fellow of AIMBE in 2011, and a Fellow of AAAS in 2013, she also serves on the organizing committee for the World Biosensors Congress and the permanent steering committee for Europt(r)odes, the European Conference on Optical Sensors. In 2003, she was awarded the Homeland Security Award (Biological, Radiological, Nuclear Field) by the Christopher Columbus Foundation and the Presidential Rank of Distinguished Senior Professional by President Bush. In 2012, she was awarded the Presidential Rank of Meritorious Senior Professional by President Obama. In 2014, she was awarded an honorary doctorate from the Agricultural University of Athens, Greece.

 

Sandy Mills is the former Vice President and Head of Global Process Chemistry in Discovery and Preclinical Sciences within the Merck Research Laboratories. After graduating from Drew University, he completed his Ph.D. in organic chemistry in Professor Peter Beak's laboratory at the University of Illinois at Urbana/Champaign. He then carried out post-doctoral studies in the laboratories of Professor Clayton H. Heathcock at the University of California, Berkeley as an NIH Postdoctoral Fellow. Dr. Mills joined Merck Research Laboratories in 1985 in the department of Process Research, moved to the medicinal chemistry area in 1989, returning to Process Chemistry in 2011. Dr. Mills' research at Merck has been wide-ranging, dealing with the design and synthesis of small molecules to treat asthma, pain, HIV infection, autoimmune diseases, and CNS disorders. In 1993, he was part of the team that discovered aprepitant (EMEND®), which in 2003 became the first substance P antagonist marketed for the prevention of chemotherapy-induced nausea and vomiting.  He and his group went on to identify fosaprepitant (IVEMEND®), a water-soluble prodrug of aprepitant for parenteral administration, which gained regulatory approval in 2008. Dr. Mills has been an author or co-author on more than 90 papers in professional journals on drug design, synthetic organic chemistry and the biology of medicinally active substances.  He has been an inventor or co-inventor on eighty U.S. patents covering an array of drug candidates and synthetic methods.  He is a member of the Organic Chemistry and Medicinal Chemistry Sections of the American Chemical Society, AAAS and Sigma Xi. 

 

Joseph B. Powell, Ph.D., is Shell's Chief Scientist - Chemical Engineering and a Fellow of the American Institute of Chemical Engineers (AIChE).  He joined the Process Development Department at what is now Shell Technology Center Houston in 1988, where he has led major R&D programs in new chemical processes, biofuels, and enhanced oil recovery, in addition to a Hunters innovation group.  Dr. Powell has been granted more than forty-eight U.S. patents (another 50+ pending) and several industry awards, including the A. D. Little Award for Chemical Engineering Innovation (AIChE 1998), R&D100 Award (R&D Magazine), American Chemical Society Team Innovation Award (2000), and a U. Wisconsin College of Engineering Distinguished Achievement Award (2009).  He is co-editor and chapter author for the book Sustainable Development in the Process Industries:  Cases and Impact, John Wiley & Sons, New York (2010), and has served AIChE in various roles including division and meeting programming chair, operating council, pilot plants area chair, and topical chair.  Dr. Powell obtained a Ph.D. in Chemical Engineering from the University of Wisconsin-Madison (1984), following a B.S.in Chemical Engineering from the University of Virginia (1978).    

 

Robert Roberts is the Senior Scientist at the Institute for Defense Analyses and former Director of the Science and Technology Policy Institute. He is also the former Vice President for Research and Director of IDA's Science and Technology Division.  Before joining IDA, he spent several years with the Department of Energy, and prior to that, he was associate professor of chemistry at Indiana University.  Dr. Roberts is founder, former director, and mentor for the IDA Defense Science Study Group, a program established to foster interest in national security issues among outstanding young professors of science and engineering.  Dr. Roberts received his bachelor's degree in chemistry from the Carnegie Institute of Technology (now Carnegie Mellon), his Ph.D. in physical chemistry from the University of Wisconsin, and was a National Science Foundation postdoctoral research fellow at Massachusetts Institute of Technology. 

 

Peter Rossky, NAS, received his undergraduate degree in Chemistry summa cum laude from Cornell University and his Ph.D. in Chemical Physics from Harvard. After postdoctoral research in the area of ionic solution theory, in 1979 he joined the faculty at the University of Texas at Austin. In 2014, he joined the faculty at Rice University as the Harry C. and Olga K. Wiess Chair in Chemistry, Professor of Chemical and Biomolecular Engineering, and Dean of the Wiess School of Natural Sciences. Rossky has published more than 250 papers in the fields of solution chemistry, computer simulation, and theoretical chemistry. His work has emphasized application of theory to elucidating the molecular-level description of liquid-state chemistry, particularly aqueous solutions, as well as the computational treatment of quantum effects in condensed phase chemistry. Areas of application have included, first, biologically relevant solutions, where he has been a major contributor in the area of biopolymer hydration. His work on new computer simulation methods for studying condensed phase photochemistry has emphasized not only the chemistry, but also the interpretation of observable ultrafast transient spectroscopy. Rossky has served on the Editorial Boards of a number of leading chemistry journals, including "Accounts of Chemical Research," "Chemical Physics Letters," "The Journal of Chemical Physics," "The Journal of Physical Chemistry," "The Journal of Chemical Theory and Computation", and “Proceedings of the National Academy of Sciences USA”. Recognitions include receipt of the ACS Physical Division Award in Theoretical Chemistry, the ACS Hildebrand Award in the Experimental and Theoretical Chemistry of Liquids, and election as a member of the American Academy of Arts and Sciences and the U. S. National Academy of Sciences.

 

Darlene J.S. Solomon, Ph.D., is Chief Technology Officer and Senior Vice President at Agilent Technologies.  Her responsibilities include developing the company's long-term technology strategy and overseeing the alignment of Agilent's objectives with its centralized research-and-development activities.  Solomon brings extensive experience in R&D and management to her current leadership role at Agilent. She joined Hewlett-Packard Laboratories in 1984 as a member of the technical staff, subsequently holding a variety of research and management positions there. She joined Agilent Technologies in 1999 as director of the Life Sciences Technologies Laboratory in Agilent Laboratories, and as senior director, research and development/technology for Agilent's Life Sciences and Chemical Analysis business. Prior to her current post, Solomon was vice president and director of Agilent Laboratories. 

Solomon received her bachelor's degree in chemistry from Stanford University, a doctorate in bioinorganic chemistry from the Massachusetts Institute of Technology, and completed Stanford University's Executive Development Program.  With numerous patents and publications to her name, Solomon was inducted into the Women in Technology International's Hall of Fame in 2001, received the YWCA Tribute to Women and Industry Award in 2004, and named to Diversity Journal's Women Worth Watching in 2007 and to Corporate Board Member's 50 Top Women in Technology in 2008.  She also serves on multiple academic and government advisory and review boards, including the National Academy of Sciences Forum on Synthetic Biology, Visiting Committee for Advanced Technology for the National Institutes of Standards and Technology (currently VCAT Vice Chair), UK Innovation and Knowledge Centre, Stanford University Interdisciplinary Biosciences Advisory Council, UC Berkeley's College of Chemistry, Wall Street Journal's Innovation Awards, Bay Area Science and Innovation Consortium (BASIC) and A-STAR Board for Singapore Economic Development (2004-10). 

 

 

This material is based upon work supported by the U.S. Department of Energy under Award No. DE-FG02-07ER15872

 

This material is based upon work supported by the National Science Foundation under Grant No. CHE-0925448

 

For more information on the Board on Chemical Sciences and Technology, please contact Elizabeth Finkelman (efinkelman@nas.edu).